Apotea (APOTEA) — Cash Flow-to-Debt Ratio
Latest as of March 2026:
0.09x
Apotea (APOTEA) has a Cash Flow-to-Debt Ratio of 0.09x as of March 2026, meaning its operating cash flow of Skr112.50 Million could theoretically repay 0% of its total liabilities (Skr1.28 Billion) in one year. Check Apotea (APOTEA) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
0.09x
Operating CF / Total Liabilities
Operating Cash Flow
Skr112.50 Million
SEK
Total Liabilities
Skr1.28 Billion
SEK
Data as of
Mar 2026
Most recent filing
Apotea Cash Flow-to-Debt Ratio (2022–2025)
Historical debt coverage capacity for Apotea across 4 annual periods. Also explore Apotea assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Apotea (2022–2025)
Year-by-year debt coverage analysis for Apotea. For market capitalisation and broader financial context, see APOTEA stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.30x | Skr333.30 Million | Skr1.12 Billion | ▲ +43.0% |
| 2024 | 0.21x | Skr206.20 Million | Skr991.70 Million | ▼ -12.2% |
| 2023 | 0.24x | Skr215.80 Million | Skr911.30 Million | ▲ +574.7% |
| 2022 | 0.04x | Skr31.50 Million | Skr897.50 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.